| 000 | 01519 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514011734.0 | ||
| 264 | 0 | _c20011018 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(01)06125-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAllahabadia, A | |
| 245 | 0 | 0 |
_aMHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 2001 |
||
| 300 |
_a984-5 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAbatacept |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aAntigens, CD |
| 650 | 0 | 4 |
_aAntigens, Differentiation _xgenetics |
| 650 | 0 | 4 | _aCTLA-4 Antigen |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, MHC Class II _xgenetics |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGraves Disease _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoconjugates |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 700 | 1 | _aHeward, J M | |
| 700 | 1 | _aNithiyananthan, R | |
| 700 | 1 | _aGibson, S M | |
| 700 | 1 | _aReuser, T T | |
| 700 | 1 | _aDodson, P M | |
| 700 | 1 | _aFranklyn, J A | |
| 700 | 1 | _aGough, S C | |
| 773 | 0 |
_tLancet (London, England) _gvol. 358 _gno. 9286 _gp. 984-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(01)06125-6 _zAvailable from publisher's website |
| 999 |
_c11504303 _d11504303 |
||